Here, we present the first evidence that the expression of B7x, but not other co-inhibitory molecules, is induced by HDAC inhibitor treatment and is associated with HDAC inhibitor resistance in colorectal cancer. The gene discussed is HDAC9; the disease is colorectal cancer.